Leader Earwax Removal Kit Recall Due to Subpotent Drug
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Bell Pharmaceuticals, Inc. is recalling 5,471 units of Leader Carbamide Peroxide earwax removal products nationwide due to low pH and reduced assay levels.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 9, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, otc-drug.
What Happened
Bell Pharmaceuticals, Inc. initiated a voluntary recall of Leader earwax removal products after testing showed the drug was subpotent, with low pH and significantly reduced assay (~0.6% vs expected ~6-7%).
Which Products Are Affected
- LEADER, Carbamide Peroxide 6.5%, 0.5 Fl Oz (15 mL)
- a) Kit with 1 rubber bulb syringe and 0.5 FL OZ drops (NDC 70000-0689-1)
- b) 1 bottle (NDC 70000-0688-1)
- Distributed by Cardinal Health, Dublin, OH 43017
- UPCs: 0096295143799, 0096295143782
- Lots: a) 1505333 (exp. 2027-04); b) 1505144, 1505302 (exp. 2027-04)
- Total units: 5,471
- Distribution: U.S. Nationwide
- Recall number: D-0685-2026
What You Should Do
Consumers should check lot numbers on affected products. The recall is ongoing and was initiated via letter.
Why This Matters
The subpotent formulation may reduce the product's effectiveness as an earwax removal aid.
Source
FDA recall D-0685-2026 (Class II), report date 2026-07-22.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (969 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 9, 2026.
Frequently Asked Questions
Common questions about this FDA recall.